Background Nanotechnology has been manufactured from medicinal plants to develop safe,
and effective antischistosmal alternatives to replace today's therapies. The aim of the study …

Hepatic fibrosis is one of the most critical diseases of wounded tissues that arise from
different caustic agents, especially viral hepatitis, bilharzia, chemical-and drug-induced …

The main objective of this work is preparation of mesoporous silica nanoparticles loaded
with praziquantel (PZQ-Si) in order to enhance the therapeutic efficacy of praziquantel …

The roots of Ozoroa pulcherrima Schweinf are used in traditional medicine to treat intestinal
helminthiasis. The aim of this study was to assess the effect of Ozoroa pulcherrima roots …

2. Methods This study is registered in PROSPERO under the number CRD42018095821.
PROSPERO is an international database of prospectively recorded systematic reviews in …

Background Undernutrition and schistosomiasis are public health problems and often occur
in low and middle-income countries. Protein undernutrition can alter the host-parasite …

Schistosomiasis, a major parasitic illness, has high morbidity and negative financial effects
in subtropical and tropical countries, including Egypt. The present study investigated the …

The present study was designed to assess the relationship between anti-schistosomal effect
of the antimalarial drug mefloquine (Mef) and the oxidative stress status of Schistosoma …

Schistosomiasis remains to be the most common fibrotic disease resulting from inflammation
and deposition of scar tissue around trapped parasitic eggs in the liver. Though …

Currently, praziquantel (PZQ) is the only drug of choice used for treatment of human
schistosomes because of its safety and broad-spectrum activity. It is reported that the …